351 news items
Page 2 of 18
7z0wuvxm7zkpapin4ov
26 Mar 24
-value portfolio of innovative vaccines, encompassing over ten potential blockbuster varieties. These encompass areas such as cervical cancer, shingles
klm4le sjq944gq19cnupidgvz7da
26 Mar 24
, fallopian tube, or primary peritoneal cancer, who have
zv1 9uibgmzep194cforpiwb3s7ews8
25 Mar 24
. This shift encompasses various strategies, including routine screenings for breast and cervical cancer, vaccination against HPV to prevent cervical
ysaxu9d6gbsfcdokjpw6
STRO
25 Mar 24
cancers - - Compelling anti-leukemic activity of luvelta in pediatric patients with relapsed/refractory CBF2AT3-GLIS2 AML
ey0izslg2x51d3loi mhfoqjt1zr3tv2w6vjiq1n9jz0qr2cmcxrx
MRK
25 Mar 24
, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine
8rokvwd24loqkm5dz44hy35q5kxvfjc2pib2cyav8nk3yznkyu24sn48fn
25 Mar 24
the Sample Report.Cancer Vaccines Market by Technology
i7qbsbymoaoc5ub58er9 rdcz
CYTO
25 Mar 24
, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira's SemaPhore
gbbi563qsy79n8iqygci11fb7kz2dpmz7ff6flez6v5o
IMNN
25 Mar 24
), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, announces
999h3dlhbu n7y2qgfcf6iesus
25 Mar 24
of a Scientific Advisory Committee from world-renowned cancer institutions – BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO
5hg53s9b7gx2d5nc9kv93yw67ijx2f dnnvzyl5iqfvnxbka7338
22 Mar 24
-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using
4m2w5luu3ku1xrzpe2pp7t7j pwnnejpvvgtcpsg6hnfert4szvq0yewon7v
IVVD
22 Mar 24
to COVID-19 vaccination including, for example, hematologic malignancies (blood cancers) or treatment with immunosuppressive therapy after a solid organ
5ycuelh 5ml7czv
IVVD
22 Mar 24
to COVID-19 vaccination including, for example, hematologic malignancies (blood cancers) or treatment with immunosuppressive therapy after a solid organ
9iaki4uk49pfii4xkstxg334
22 Mar 24
:The COVID-19 pandemic significantly impacted the CDMO market. As the pharmaceutical industry raced to develop vaccines and treatments
bsylic5prnk1yh po6gfl607btevby0
22 Mar 24
, $10 million to expand cancer screening and vaccination access to medically underserved communities, and $10 million to educate the public about
g8ecz8rhyfgnvfc9dl2
22 Mar 24
animal vaccine market was estimated to grow from USD 14.27 billion in 2022 to soar an estimated USD 36.91 billion by 2032, at 10% CAGR
0h2f5caj24i3cs18rn9t3yszpr6tjf1qlxmvlknxnf29rizf1jjdcvvpq
HOOK
22 Mar 24
Phase 2 data for HB-200 in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancers in the first line setting
639aif2v0l1ttn7 j729xty9o51d4sq7dop6ft5b6mza0g
21 Mar 24
demand for genetically engineered therapeutic proteins that offer improved disease resistance, their use in the treatment of cancer, and increased
67c4en3gnyo emb8d
21 Mar 24
cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© 'neoantigen' tumor cell construct platform
irg0tyh4z1ubuq8lvupwbqvgors2
IMNN
21 Mar 24
-generation vaccines, announces that the Company will host a conference call at 10:00 a.m. ET on Thursday, March 28, 2024 to discuss financial results
kwovtwu9to0551r2 r8mngbhgeyk6zbvv6yv32uzfnqf
21 Mar 24
cancers, including breast cancer, lymphoma, and leukemia. With the global burden of cancer expected to rise due to factors like aging populations